Market Overview

Abiomed Wins Federal Contract to Provide Impalla Platform to Vets

Share:
Related ABMD
Benzinga's Top Initiations
Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0/LD Pre-Market Approval Supplements
3 Reasons Why Cyberonics (CYBX) is a Great Stock to Buy (Zacks)

Abiomed, Inc. (Nasdaq: ABMD), a leading provider of breakthrough heart support technologies, today reported that it received approval from the U.S. Department of Veterans Affairs to be included on its authorized Veteran's Administration (VA) Federal Supply Schedule in which Abiomed can provide the Impella® platform to VA medical facilities, Department of Defense (DOD) hospitals and other federal agencies.

This contract allows the Company to make the Impella platform available through an automated online database for the approximately 169 VA facilities and the approximately 42 DOD hospitals in the United States. The five year contract will run until August 2018.

Posted-In: News

 

Related Articles (ABMD)

View Comments and Join the Discussion!

Get Benzinga's Newsletters